AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/1080
Title: A Retrospective Study of Topical Lidocaine 5% Plasters in Chronic Off-Label Pain Conditions
Authors: Menz, B
Wahba, M
Slattery, P
Thiruvenkatarajan, V
Johnson, J
Keywords: Chronic Pain
Lidocaine
Herpes Zoster
Retrospective Studies
Abstract: Dear Editor, Among many formulations, lidocaine (lignocaine) is available in a transdermal plaster (patch) containing 5% w/w lidocaine (Versatis®, trademark of Grünenthal GmbH used by Seqirus as an authorized user). This formulation is approved for symptomatic treatment of neuropathic pain associated with herpes zoster infection (post-herpetic neuralgia); thus, use of these plasters for other pain conditions is considered off-label. The use of lidocaine 5% plasters (L5%P) in off-label indications has been explored in a limited number of small studies. Currently, L5%P are recommended as a second-line treatment for neuropathic pain in a systematic review by Finnerup et al., limited by weak...
Description: Ethics and governance: This project was approved by the Southern Adelaide Local Health Network Human Research Ethics Committee under reference AUD/19/SAC/76 and site-specific assessment reference AR/19/SAC/76
URI: http://hdl.handle.net/11055/1080
ISSN: 1526-2375
Appears in Collections:Scholarly and Clinical

Show full item record

Page view(s)

56
checked on Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.